Citation Impact
Citing Papers
Rhizobium induces DNA damage in Caenorhabditis elegans intestinal cells
2019 StandoutNobel
SuFEx-enabled, agnostic discovery of covalent inhibitors of human neutrophil elastase
2019 StandoutNobel
Diversity oriented clicking delivers β-substituted alkenyl sulfonyl fluorides as covalent human neutrophil elastase inhibitors
2022 StandoutNobel
Reduced oxidative and nitrosative damage in murine experimental colitis in the absence of inducible nitric oxide synthase
1999
Reactive oxygen species activity and lipid peroxidation in Helicobacter pylori associated gastritis: relation to gastric mucosal ascorbic acid concentrations and effect of H pylori eradication
1998
Interleukin-8 Induction by Helicobacter pylori in Gastric Epithelial Cells is Dependent on Apurinic/Apyrimidinic Endonuclease-1/Redox Factor-1
2006
Loss of T Cell and B Cell Quiescence Precedes the Onset of Microbial Flora-Dependent Wasting Disease and Intestinal Inflammation in Gimap5-Deficient Mice
2010 StandoutNobel
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2007 Standout
Reactive oxygen species activity, mucosal lipoperoxidation and glutathione in Helicobacter pylori‐infected gastric mucosa
2001
Inflammation and cancer
2002 StandoutNature
α1-antitrypsin deficiency
2005
A sensitivity to oxidative stress is linked to chromosome 11 but is not due to a difference in single strand DNA breakage or repair
1993
Small-Vessel Vasculitis
1997 Standout
Oxidative Stress, Inflammation and Neutrophil Superoxide Release in Patients with Crohn’s Disease: Distinction Between Active and Non-active Disease
2008
Helicobacter pylori and H2O2 increase AP endonuclease-1/redox factor-1 expression in human gastric epithelial cells
2004
Redox biology and gastric carcinogenesis: the role ofHelicobacter pylori
2011
Ulcerative Colitis
2011 Standout
Reactive oxygen species and antioxidant machinery in abiotic stress tolerance in crop plants
2010 Standout
Oxidative stress in ulcerative colitis-associated carcinogenesis
2008
Ascorbic acid may protect against human gastric cancer by scavenging mucosal oxygen radicals
1996
Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease.
1996
Diagnostic Precision of Anti-Saccharomyces cerevisiae Antibodies and Perinuclear Antineutrophil Cytoplasmic Antibodies in Inflammatory Bowel Disease
2006
Differential Helicobacter pylori infection rates in two contrasting gastric cancer risk regions of South China
1999
The resurgence of platinum-based cancer chemotherapy
2007 Standout
Raynaud’s phenomenon: Epidemiology and risk factors
2002
Depletion of luminal iron alters the gut microbiota and prevents Crohn's disease-like ileitis
2010
Exacerbating Role of γδ T Cells in Chronic Colitis of T-Cell Receptor α Mutant Mice
2007
Anti-neutrophil cytoplasmic antibodies: Current diagnostic and pathophysiological potential
1994
NOX enzymes and the biology of reactive oxygen
2004 Standout
Helicobacter pylori CagA-positive Strains Affect Oxygen Free Radicals Generation by Gastric Mucosa
2001
Stimuli-responsive nanocarriers for drug delivery
2013 Standout
A superoxide dismutase/catalase mimetic nanomedicine for targeted therapy of inflammatory bowel disease
2016
Oxidants and free radicals in inflammatory bowel disease
1994
Inflammatory bowel disease: cause and immunobiology
2007 Standout
Helicobacter pylori Reduces Intracellular Glutathione in Gastric Epithelial Cells
2000
ANTIOXIDANT STATUS AND LIPID PEROXIDATION IN COLORECTAL CANCER
2001
Oxidative stress as a pathogenic factor in inflammatory bowel disease — radicals or ridiculous?
2002
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Human nutrition, the gut microbiome and the immune system
2011 StandoutNature
VIRULENCE AND PATHOGENICITY OF HELICOBACTER PYLORI
2000
Oxidative Inactivation of Gastric Peroxidase by Site-Specific Generation of Hydroxyl Radical and Its Role in Stress-Induced Gastric Ulceration
1998
A phase II trial of ZD0473 in platinum-pretreated ovarian cancer
2002
Helicobacter pylori infection enhances mucosal interleukin-1β, interleukin-6, and the soluble receptor of interleukin-2
1996
Sequence-dependent synergism between the new generation platinum agent ZD0473 and paclitaxel in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines
2002
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
2001 StandoutNature
Increases in free radicals and cytoskeletal protein oxidation and nitration in the colon of patients with inflammatory bowel disease
2003
Crohn's disease
2016 Standout
Inflammatory Bowel Disease
2002 Standout
Protective effects of M40403, a superoxide dismutase mimetic, in a rodent model of colitis
2001
Retention of activity by the new generation platinum agent AMD0473 in four human tumour cell lines possessing acquired resistance to oxaliplatin
2002
Inflammatory bowel disease--a radical view.
1993
Molecularly defined HLA-DR2 alleles in ulcerative colitis and an antineutrophil cytoplasmic antibody-positive subgroup
1995
Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease
2001
Orally delivered thioketal nanoparticles loaded with TNF-α–siRNA target inflammation and inhibit gene expression in the intestines
2010
Ulcerative Colitis as A Progressive Disease: The Forgotten Evidence
2011
Inducible nitric oxide synthase‐dependent DNA damage in mouse model of inflammatory bowel disease
2005
Ulcerative colitis: a genetically heterogeneous disorder defined by genetic (HLA class II) and subclinical (antineutrophil cytoplasmic antibodies) markers.
1993
Superoxide production and expression of NAD(P)H oxidases by transformed and primary human colonic epithelial cells
2003
Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells: The pathogenic and diagnostic implications
2001
Ulcerative colitis
2016 Standout
Asthma phenotypes: the evolution from clinical to molecular approaches
2012 Standout
Inflammation and the development of pancreatic cancer
2002
Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease
2002
Helicobacter pyloriInfection
2002 Standout
Angiotensin II Type 1–Receptor Activating Antibodies in Renal-Allograft Rejection
2005 Standout
Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary Prevention
2007 Standout
Dietary antioxidants and DNA damage in patients on long-term acid-suppression therapy: a randomized controlled study
2002
ZD0473 treatment in lung cancer: an overview of the clinical trial results
2002
Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease
1995
Helicobacter pylori Eradication to Prevent Gastric Cancer in a High-Risk Region of China
2004 Standout
Anti-Saccharomyces Cerevisiae Antibodies (ASCA), Phenotypes of IBD, and Intestinal Permeability: A Study in IBD Families
2001
Inflammatory bowel disease: Etiology and pathogenesis
1998 Standout
Multidimensional degradomics identifies systemic autoantigens and intracellular matrix proteins as novel gelatinase B/MMP-9 substrates
2009
Intercellular adhesion molecule 1 gene associations with immunologic subsets of inflammatory bowel disease
1995
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
2009 Standout
Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins
1994
Lipid oxidation and improving the oxidative stability
2010 Standout
Toward A Quantitative Comparative Toxicology of Organic Compounds
1989
Activator protein‐1 signalling pathway and apoptosis are modulated by poly(ADP‐ribose) polymerase‐1 in experimental colitis
2004
Neutrophil recruitment and function in health and inflammation
2013 Standout
Global burden of COPD: risk factors, prevalence, and future trends
2007 Standout
Inhibitors of poly (ADP-ribose) polymerase modulate signal transduction pathways in colitis
2003
Evaluation of serological markers to differentiate between ulcerative colitis and Crohn's disease: pANCA, ASCA and agglutinating antibodies to anaerobic coccoid rods
2002
The bactericidal effects of Lactobacillus acidophilus, garcinol and Protykin® compared to clarithromycin, on Helicobacter pylori
2003
Catalase and Superoxide Dismutase Secreted from Helicobacter pylori
1997
Interleukin-1 polymorphisms associated with increased risk of gastric cancer
2000 StandoutNature
Molecular and cellular mechanisms involved in Helicobacter pylori-induced inflammation and oxidative stress
2002
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
2007 Standout
Differential Proteolytic Enzyme Activity in Eosinophilic and Neutrophilic Asthma
2005
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Association of cytotoxin production and neutrophil activation by strains of Helicobacter pylori isolated from patients with peptic ulceration and chronic gastritis.
1996
Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That Blossomed
2012 Standout
Activation of multiple protein kinases induced by cross-linking of FcγRII in human neutrophils
1995
Host-Bacterial Mutualism in the Human Intestine
2005 StandoutScience
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Superoxide dismutases in gastric and esophageal cancer and the prognostic impact in gastric cancer.
2000
Resistance of Crohn’s Disease T Cells to Multiple Apoptotic Signals Is Associated with a Bcl-2/Bax Mucosal Imbalance
1999
Chem-Bioinformatics and QSAR: A Review of QSAR Lacking Positive Hydrophobic Terms
2001 Standout
Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl.
1995 Standout
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Oxidative Nucleobase Modifications Leading to Strand Scission
1998 Standout
Paratuberculosis
1994
Biocompatible Reactive Oxygen Species (ROS)‐Responsive Nanoparticles as Superior Drug Delivery Vehicles
2014
Implications of antioxidant enzymes in human gastric neoplasms
2009
Sphingosine Blocks Human Polymorphonuclear Leukocyte Phagocytosis Through Inhibition of Mitogen-Activated Protein Kinase Activation
1999 StandoutNobel
Polycyclic Polyprenylated Acylphloroglucinols
2006 Standout
Analysis of intestinal haem-oxygenase-1 (HO-1) in clinical and experimental colitis
2005
Johne's Disease, Inflammatory Bowel Disease, andMycobacterium paratuberculosis
2004
Helicobacter pyloriInfection Induces Oxidative Stress and Programmed Cell Death in Human Gastric Epithelial Cells
2007
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
Characterization of a Helicobacter pylori neutrophil-activating protein
1995
Characterization of a Novel, Water-Soluble Hydrogen Sulfide–Releasing Molecule (GYY4137)
2008
Annexins: From Structure to Function
2002 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Helicobacter pylori Virulence and Genetic Geography
1999 StandoutScience
The Role of Serine Proteases and Antiproteases in the Cystic Fibrosis Lung
2015
In vitro study of antioxidant activity of fruit
2005 StandoutNobel
A Near-IR Reversible Fluorescent Probe Modulated by Selenium for Monitoring Peroxynitrite and Imaging in Living Cells
2011 Standout
Protective role of heme oxygenase-1 on trinitrobenzene sulfonic acid-induced colitis in rats
2001
Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer
1996 Standout
Works of Tim Stevens being referenced
Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo.
1994
Mucosal reactive oxygen metabolite production in duodenal ulcer disease.
1992
Anti-neutrophil antibodies in inflammatory bowel disease: prevalence and diagnostic role.
1992
α1-Antitrypsin, Old Dog, New Tricks
2007
AZD9668: Pharmacological Characterization of a Novel Oral Inhibitor of Neutrophil Elastase
2011
Anti-endothelial cell antibodies in inflammatory bowel disease
1993
Inhibition of lipopolysaccharide-mediated human monocyte activation, in vitro, by α1-antitrypsin
2004
Divergent effects of α1-antitrypsin on neutrophil activation, in vitro
2004
FACTOR VIII RELATED ANTIGEN IN CONNECTIVE TISSUE DISEASE PATIENTS AND RELATIVES
1990
Chemiluminescence assay of mucosal reactive oxygen metabolites in inflammatory bowel disease
1992
Do Native and Polymeric α 1 -Antitrypsin Activate Human Neutrophils In Vitro ?
2006
Circulating von Willebrand factor in inflammatory bowel disease.
1992
Antibodies to Human Recombinant Lipocortin-L in Inflammatory Bowel Disease
1993
Rapid modification of ribosomal S6 kinase II (S6KII) in rabbit peritoneal neutrophils stimulated with chemotactic factor fMet-Leu-Phe
1994
Circulating antibodies to heat-shock protein 60 in Crohn's disease and ulcerative colitis
1992
Experimental determination and prediction of partition coefficients of thioureas and their toxicity to
1986
Preclinical and clinical overview of the novel platinum complex, ZD0473 (cis-amminedichloro[2-methylpyridine] platinum[II])
2000